Citius Pharmaceuticals Completes $6 Million Direct Offering to Fuel Growth Citius Pharmaceuticals has successfully finalized a direct offering worth $6 million. The proceeds will propel the launch of its innovative product, LYMPHIR, and further its development initiatives.

Citius Pharmaceuticals Completes $6 Million Direct Offering to Fuel Growth #United_States #Cranford #Citius_Pharmaceuticals #LYMPHIR #Nasdaq_CTXR